微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -11.06% | -95.75% | -280.07% | 129/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -2.91% | -304.17% | 93.68% | 125/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -46.07% | 11.18% | -1795.89% | 128/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -2.43% | -27.89% | 56.99% | 117/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -5.65% | -1186.54% | -684.72% | 128/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.72% | -294.59% | 98.61% | 116/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -51.87% | -91.61% | -2630% | 129/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -1.9% | -262.39% | -465.38% | 115/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.52% | -60.31% | 40.54% | 95/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.37% | -65.09% | 101.37% | 95/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -27.07% | -802.33% | -2413.68% | 129/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 1.17% | -4.1% | -10.69% | 103/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.31% | 47.19% | 23.58% | 98/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.06% | 2.91% | 135.33% | 84/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -3% | 14.53% | -345.9% | 121/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 1.22% | -41.63% | 37.08% | 105/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 0.89% | -7.29% | -13.59% | 111/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.03% | -20.77% | 129.34% | 89/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | -3.51% | -124.81% | -267.94% | 123/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 2.09% | -86.12% | 117.71% | 103/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 0.96% | -92.95% | -26.15% | 112/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.3% | 1.56% | -90.81% | 87/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 14.15% | 242.62% | -6.04% | 70/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 15.06% | 160.1% | 10.57% | 38/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 13.62% | 252.85% | 964.06% | 34/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.28% | -22.37% | -69.01% | 55/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 4.13% | 4.56% | -28.67% | 100/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 5.79% | -38.47% | 50% | 46/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 3.86% | -5.85% | 134.11% | 52/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.65% | -27.37% | -58.26% | 34/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 3.95% | -69.57% | -58.02% | 88/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 9.41% | -34.7% | 129.51% | 27/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.1% | -61.06% | 80.62% | 36/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.27% | 2% | -82.51% | 27/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 12.98% | -37.17% | -9.92% | 52/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 14.41% | 2% | -30.25% | 10/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2016-12-31 | 20.66% | -3.5% | -3.5% | 22/141 | 16.44% | 基蛋生物 | 23.11% | 行业排名> |